These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32018211)

  • 1. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
    Guo R; Liu N; Liu H; Zhang J; Zhang H; Wang Y; Baruscotti M; Zhao L; Wang Y
    Phytomedicine; 2020 Mar; 68():153171. PubMed ID: 32018211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling.
    Gao J; Zhang K; Wang Y; Guo R; Liu H; Jia C; Sun X; Wu C; Wang W; Du J; Chen J
    Pharmacol Res; 2020 May; 155():104739. PubMed ID: 32135248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity.
    Feng X; Wang Y; Chen W; Xu S; Li L; Geng Y; Shen A; Gao H; Zhang L; Liu S
    Aging (Albany NY); 2020 Mar; 12(5):4178-4192. PubMed ID: 32139662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.
    Meng G; Liu J; Liu S; Song Q; Liu L; Xie L; Han Y; Ji Y
    Br J Pharmacol; 2018 Apr; 175(8):1126-1145. PubMed ID: 28503736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
    Yue Z; Ma Y; You J; Li Z; Ding Y; He P; Lu X; Jiang J; Chen S; Liu P
    Exp Cell Res; 2016 Oct; 347(2):261-73. PubMed ID: 27423420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3.
    Pillai VB; Samant S; Sundaresan NR; Raghuraman H; Kim G; Bonner MY; Arbiser JL; Walker DI; Jones DP; Gius D; Gupta MP
    Nat Commun; 2015 Apr; 6():6656. PubMed ID: 25871545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
    Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
    Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes.
    You J; Yue Z; Chen S; Chen Y; Lu X; Zhang X; Shen P; Li J; Han Q; Li Z; Liu P
    Acta Physiol (Oxf); 2017 May; 220(1):58-71. PubMed ID: 27614093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalin inhibits pressure overload-induced cardiac hypertrophy by regulating the SIRT3-dependent signaling pathway.
    Cai Y; Jiang S; Huang C; Shen A; Zhang X; Yang W; Xiao Y; Gao S; Du R; Zheng G; Yan T; Craig Wan C
    Phytomedicine; 2023 Jun; 114():154747. PubMed ID: 36931095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure.
    Qian K; Tang J; Ling YJ; Zhou M; Yan XX; Xie Y; Zhu LJ; Nirmala K; Sun KY; Qin ZH; Sheng R
    EBioMedicine; 2023 Dec; 98():104863. PubMed ID: 37950995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway.
    Zhang Y; Sun M; Wang D; Hu Y; Wang R; Diao H; Shao X; Li Y; Li X; Leng M; Wang L; Yan M; Rong X; Guo J
    Biomed Pharmacother; 2022 Apr; 148():112696. PubMed ID: 35183007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.
    Li ZY; Lu GQ; Lu J; Wang PX; Zhang XL; Zou Y; Liu PQ
    Acta Pharmacol Sin; 2023 Mar; 44(3):546-560. PubMed ID: 36042291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress.
    Tomczyk MM; Cheung KG; Xiang B; Tamanna N; Fonseca Teixeira AL; Agarwal P; Kereliuk SM; Spicer V; Lin L; Treberg J; Tong Q; Dolinsky VW
    Circ Heart Fail; 2022 May; 15(5):e008547. PubMed ID: 35418250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.
    Pillai VB; Bindu S; Sharp W; Fang YH; Kim G; Gupta M; Samant S; Gupta MP
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H962-72. PubMed ID: 26873966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis.
    Peng F; Liao M; Jin W; Liu W; Li Z; Fan Z; Zou L; Chen S; Zhu L; Zhao Q; Zhan G; Ouyang L; Peng C; Han B; Zhang J; Fu L
    Signal Transduct Target Ther; 2024 May; 9(1):133. PubMed ID: 38744811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology integrated with experimental validation to elucidate the mechanisms of action of the Guizhi-Gancao Decoction in the treatment of phenylephrine-induced cardiac hypertrophy.
    Yang K; Shan X; Songru Y; Fu M; Zhao P; Guo W; Xu M; Chen H; Lu R; Zhang C
    Pharm Biol; 2024 Dec; 62(1):456-471. PubMed ID: 38773737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
    Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
    J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.